Skip to main content

Table 1 Patients characteristics (n = 47)

From: Use of percutaneous microwave ablation for the treatment of bone tumors: a retrospective study of clinical outcomes in 47 patients

CharacteristicsNo. of patientsPercentage (%)
Age (years)Mean±SD (years)43.1±16.6
Range8–71
GenderMale2246.8%
Female2553.2%
VAS score on admission<62042.6%
≥62757.4%
Tumor pathologyBenign bone tumors (n = 26)Osteoid osteoma623.1%
Osteoblastoma519.2%
Enchondroma1246.2%
Osteofibrous dysplasia27.7%
Nonossifying fibroma13.8%
Malignant bone tumors (n = 21)Bone metastases1676.2%
Multiple myeloma523.8%
Lesion locationSpine or sacrum1531.9%
Upper extremity612.8%
Lower extremity1736.2%
Pelvis919.1%
Surgical managementMWA1429.8%
MWA+BC1838.3%
Endoscopic MWA+IAB/BC1531.9%
Follow-up (months)Mean±SD (months)4.8±1.6
Range2–9
  1. VAS Visual analog scale, MWA Microwave ablation, BC Bone cement, IAB Injectable artificial bone